LIFEMD INC (LFMD) Stock Fundamental Analysis
USA - NASDAQ:LFMD - US53216B1044 - Common Stock
6.3 USD
+0.07 (+1.12%)
6.39 USD
+0.09 (+1.43%)
Overall LFMD gets a fundamental rating of 3 out of 10. We evaluated LFMD against 35 industry peers in the Health Care Technology industry. LFMD may be in some trouble as it scores bad on both profitability and health. LFMD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
LFMD had negative earnings in the past year.
LFMD had a positive operating cash flow in the past year.
LFMD had negative earnings in each of the past 5 years.
In multiple years LFMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -12.28%, LFMD perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFMD has a Gross Margin of 87.57%. This is amongst the best in the industry. LFMD outperforms 94.29% of its industry peers.
LFMD's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for LFMD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMD has more shares outstanding
Compared to 5 years ago, LFMD has more shares outstanding
LFMD has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.71, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
LFMD has a Altman-Z score (0.71) which is in line with its industry peers.
LFMD has a debt to FCF ratio of 2.31. This is a good value and a sign of high solvency as LFMD would need 2.31 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.31, LFMD is doing good in the industry, outperforming 77.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Altman-Z | 0.71 |
ROIC/WACCN/A
WACC10.29%
2.3 Liquidity
LFMD has a Current Ratio of 0.77. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.77, LFMD is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
LFMD has a Quick Ratio of 0.77. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
LFMD has a worse Quick ratio (0.72) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
LFMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.00%, which is quite impressive.
LFMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.74%.
The Revenue has been growing by 76.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
3.2 Future
Based on estimates for the next years, LFMD will show a very strong growth in Earnings Per Share. The EPS will grow by 40.83% on average per year.
Based on estimates for the next years, LFMD will show a quite strong growth in Revenue. The Revenue will grow by 19.29% on average per year.
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5YN/A
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 26.47, which means the current valuation is very expensive for LFMD.
71.43% of the companies in the same industry are more expensive than LFMD, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.92, LFMD is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 26.47 |
4.2 Price Multiples
LFMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LFMD is cheaper than 68.57% of the companies in the same industry.
LFMD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LFMD is cheaper than 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.35 | ||
| EV/EBITDA | 30.38 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LFMD's earnings are expected to grow with 40.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.23%
EPS Next 3Y40.83%
5. Dividend
5.1 Amount
No dividends for LFMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.3
+0.07 (+1.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners53.98%
Inst Owner Change0.11%
Ins Owners18.82%
Ins Owner Change2.51%
Market Cap283.75M
Revenue(TTM)245.56M
Net Income(TTM)-9034000
Analysts81.33
Price Target13.13 (108.41%)
Short Float %12.95%
Short Ratio4.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)0%
PT rev (3m)-8.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-89.82%
EPS NY rev (3m)-859.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 26.47 | ||
| P/S | 1.16 | ||
| P/FCF | 42.35 | ||
| P/OCF | 14.57 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 30.38 |
EPS(TTM)-0.21
EYN/A
EPS(NY)0.24
Fwd EY3.78%
FCF(TTM)0.15
FCFY2.36%
OCF(TTM)0.43
OCFY6.86%
SpS5.45
BVpS-0.04
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% | ||
| FCFM | 2.73% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Debt/EBITDA | 0.41 | ||
| Cap/Depr | 120.74% | ||
| Cap/Sales | 5.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 227.76% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 0.71 |
F-Score5
WACC10.29%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5YN/A
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.54%
EBIT Next 3Y69.78%
EBIT Next 5YN/A
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%
LIFEMD INC / LFMD FAQ
What is the ChartMill fundamental rating of LIFEMD INC (LFMD) stock?
ChartMill assigns a fundamental rating of 3 / 10 to LFMD.
What is the valuation status of LIFEMD INC (LFMD) stock?
ChartMill assigns a valuation rating of 4 / 10 to LIFEMD INC (LFMD). This can be considered as Fairly Valued.
What is the profitability of LFMD stock?
LIFEMD INC (LFMD) has a profitability rating of 2 / 10.
What is the financial health of LIFEMD INC (LFMD) stock?
The financial health rating of LIFEMD INC (LFMD) is 2 / 10.
Can you provide the dividend sustainability for LFMD stock?
The dividend rating of LIFEMD INC (LFMD) is 0 / 10 and the dividend payout ratio is -34.38%.